Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines

Fulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry...

Full description

Saved in:
Bibliographic Details
Main Authors: Denzel R. Woode, Harini S. Aiyer, Nicole Sie, Alan L. Zwart, Liya Li, Navindra P. Seeram, Robert Clarke
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2012/147828
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685253727191040
author Denzel R. Woode
Harini S. Aiyer
Nicole Sie
Alan L. Zwart
Liya Li
Navindra P. Seeram
Robert Clarke
author_facet Denzel R. Woode
Harini S. Aiyer
Nicole Sie
Alan L. Zwart
Liya Li
Navindra P. Seeram
Robert Clarke
author_sort Denzel R. Woode
collection DOAJ
description Fulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry extracts (Jamun-EJAE and red raspberry-RRE) and their bioactive compounds (Delphinidin-Del and Ellagic acid-EA) to inhibit cell proliferation with or without a sublethal dose of ICI in various breast cancer cell lines. ICI-sensitive (LCC1, ZR75-1, and BT474) and -resistant (LCC9, ZR75-1R) cells were subjected to treatment with berry extracts alone (0.1–100 μg/mL) or with a sub-lethal dose of ICI (<IC50 dose; 1 nM for sensitive; 1 μM for resistant cells). Extracts and Del enhanced the effect of ICI in sensitive ZR75-1 and BT474 cells primarily in an additive fashion (measured by relative index (RI)~1). In ZR75-1R cells, both EJAE and RRE synergistically enhanced the effects of ICI (15–50%; ; ). EA, in doses tested, did not have any significant effects on any of the cell lines. Finally, we found that the extracts were more effective at lower, physiologically relevant concentrations than at higher experimental doses.
format Article
id doaj-art-b948e5211ce7405d8c83d485f0beabfe
institution DOAJ
issn 2090-3170
2090-3189
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Breast Cancer
spelling doaj-art-b948e5211ce7405d8c83d485f0beabfe2025-08-20T03:23:12ZengWileyInternational Journal of Breast Cancer2090-31702090-31892012-01-01201210.1155/2012/147828147828Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell LinesDenzel R. Woode0Harini S. Aiyer1Nicole Sie2Alan L. Zwart3Liya Li4Navindra P. Seeram5Robert Clarke6Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USALombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USARoyal College of Surgeons in Ireland, Dublin, IrelandLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USADepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, USADepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, USALombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USAFulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry extracts (Jamun-EJAE and red raspberry-RRE) and their bioactive compounds (Delphinidin-Del and Ellagic acid-EA) to inhibit cell proliferation with or without a sublethal dose of ICI in various breast cancer cell lines. ICI-sensitive (LCC1, ZR75-1, and BT474) and -resistant (LCC9, ZR75-1R) cells were subjected to treatment with berry extracts alone (0.1–100 μg/mL) or with a sub-lethal dose of ICI (<IC50 dose; 1 nM for sensitive; 1 μM for resistant cells). Extracts and Del enhanced the effect of ICI in sensitive ZR75-1 and BT474 cells primarily in an additive fashion (measured by relative index (RI)~1). In ZR75-1R cells, both EJAE and RRE synergistically enhanced the effects of ICI (15–50%; ; ). EA, in doses tested, did not have any significant effects on any of the cell lines. Finally, we found that the extracts were more effective at lower, physiologically relevant concentrations than at higher experimental doses.http://dx.doi.org/10.1155/2012/147828
spellingShingle Denzel R. Woode
Harini S. Aiyer
Nicole Sie
Alan L. Zwart
Liya Li
Navindra P. Seeram
Robert Clarke
Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
International Journal of Breast Cancer
title Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
title_full Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
title_fullStr Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
title_full_unstemmed Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
title_short Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
title_sort effect of berry extracts and bioactive compounds on fulvestrant ici 182 780 sensitive and resistant cell lines
url http://dx.doi.org/10.1155/2012/147828
work_keys_str_mv AT denzelrwoode effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines
AT harinisaiyer effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines
AT nicolesie effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines
AT alanlzwart effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines
AT liyali effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines
AT navindrapseeram effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines
AT robertclarke effectofberryextractsandbioactivecompoundsonfulvestrantici182780sensitiveandresistantcelllines